We describe a ligand displacementimmunoassayfor measurementof theophyllinein serum or plasma and show it to be clinicallyuseful.A conjugateof theophylline-specific antiserum covalentlybound to micro-crystallinecelluloseand a -galactosidase-labeled theophyllinederivative is prepared as a lyophilizedreagent. Sample is added to the conjugate and, after 5-mm incubationat room temperature, the bound and displacedenzyme-ligand are separatedbybriefcentnfugation.The enzyme activityof the displacedenzyme-ligand is measuredon a spectrophotometeror centrifugalanalyzer. 
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The principle of this Ligand Displacement Immuno Assay (um.#{174}) is applicable to the measurement of a wide variety of substances.
Here we describe its use to measure theophylline in human serum.
Numerous analytical methods for theophylline have been reported. Theophylline concentrations in human serum and plasma have been determined by spectrophotometry (6), chromatography (7, 8) , and immunoassays
(9-13).
Each method has advantages,but the method of greatest use to date for analysis of multiple samples isthe homogeneous enzyme immunoassay (EMn'#{174})because of its speed and its adaptability for automation (14). The imi methoddescribed here is an alternative rapid, sensitive, and specific enzyme immunoassay for theophylline in serum.
magnetic resonance spectra were obtained with a Model VF-80A spectrometer (Varian Associates, Palo Alto, CA 94303). We used a Varian MAT44 quadrupole mass spectrometer to obtain the mass spectral data.
Synthesis of3-(4-carboxybutyl)-1 -methyixanthine.
We diesolved 1.001 g (6.03 mmol) of 1-methylxanthine in 60.3 mL of 0.1 mol/L sodium hydroxide (6.03 mmol), ifitered the solution, then lyophilized the filtrate. We dissolved the lyophilized product in 30 mL of dry dimethyl sulfoxide. After adding methyl 5-bromovalerate (1.203 g, 6.17 mmol, prepared by refluxing 5-bromovaleric acid in acidic methanol), we let this react at 55 #{176}C for 24 h. We removedthe dimethyl sulfoxide under reduced pressure, then dissolved the pale yellow residue in 250 mL of boiling acetone, removing a small amount of insoluble material by ifitration. Again, we removed the solvent from the ifitrate and chromatographed the product on Silica Gel 60 in ethyl acetate. After removing the solvent from the product, we dissolved the residue (511 mg) in 50 mL of 0.1 molIL sodium hydroxide. After we refluxed the solution for 15 To attach the antibody covalently to micro-crystalline cellulose, we modified if required, with 150 mmo)JL sodium chloride, which was also the zero calibrator.
After letting the samples stand for 5 mm, we sedimented the conjugate by centrifugation for 2 mm at 3000 x g, then measured the enzyme activity in the supernate with the micro-centrifugal analyzer. Alternatively, we mixed 500 pL of conjugate and 10 ML of specimen for 5 mm; after the centrifugation step we mixed 250 pL of supernate with 250 pL of 10 mniollL ONPG substrate solution. After incubating this for 5 mm at 37 #{176}C, we added 500 j.zL of 1 mol/L sodium carbonate solution and measured the absorbance at 405 nm.
Performance evaluation.
Clinical trials were conducted at two hospital laboratories, to collect data regarding assessments of within-run precision, between-run precision,and correlation studies to determine accuracy of the LIDIA assay (17) . Serum samples from 145 patients receiving theophylline medication were analyzed by both the EMIT theophylline assay and the LIDIA assay. Correlation was determined as described by Westgard et al. (18) .
Assay specificity. To investigate the cross reactivity of a series of compounds structurally similar to theophylline, we prepared 4 gIL stock aqueous solutions of caffeine (1,3,7-trimethylxanthine), theobromine(3,7-dimethylxanthine), 3-methylxanthine, 1-methylxanthine, and 8-chlorotheophylline. These solutionswere appropriately diluted before assay.
Effect of anticoagulants.
We also tested the following The i.mI.A theophylline assay is highly specific. Results of cross-reactivity studies of theophylline metabolites and structurally related dietary xanthines (Table 1) suggest that, even though concentrations for these compounds in serum are not well established, interferences from them in patients' samples are unlikely. This was confirmed in the clinical method comparison studies (see Table 3 ). The antiasthmatic drug dyphyllmne [7-(2,3-dihydroxypropyl)theophylline] was not investigated but, given the close structur- al resemblance to caffeine, it would be expected to have a similarcross reactivity.
The common anticoagulants heparin, EDTA, ainmonium oxalate, potassium oxalate, and trisodium citrate did not significantly affect the assay results; the variation of the observed measurements with and without added anticoagulants is within the error of the assay. Therefore, aqueous solutions, serum, or plasma can be used with validity.
The sensitivity of the assay, determined as the 95% confidence limit for analysis of 29 serum samples from patients known not to be on theophylline medication, is 1.6 mg/L (mean 0.5 mg/L, SD 0.54 mgIL). Precision studies and comparison studies with the EMIT assay for theophylline were carried out in two hospital laboratories;the resultsare given in Tables 2 and 3 (20) . In general terms, the rate constant for the association reaction is large (about 106 to 108 L mol' s') and approaches the limit set by the rate of diffusion of reactants, whereas the rate constant for the dissociation reaction is small and varies over several orders of magni- 
Mexico, 1978).
Recently a solid-phase reagent-strip assay has been de- here, in terms of both the rate and extent of displacement of the labeled drug from the immobilized antibody. The developers described a 15 mm reaction time for this "reversible complex formation" assay; however, correlation with results for patients' samples assayed by "high-pressure" liquid chromatographywas reported only for the competitivebinding assay methodology.
The LIDIA assay for theophylline reported here demonstrates that the displacement principle can be applied to produce working immunoassayswith enzyme labels. The principle is generally applicable for the measurement of a widevariety of substances of clinical interest, and it hasalso been used in the measurement of serum phenytoin and phenobarbital(to bereported elsewhere).Moreover,we have automated the procedure in our laboratory to continuousflow methodologywith on-line separationof boundand free enzyme-ligand. The mi& assay is a rapid, simple method for drug measurement, combining the advantagesof spectrophotometric assays (single reagent, linear calibration) with those of immunoassays (sensitivity, specificity).
